Clinical trial
Treatment of Head & Neck Cancer With Chemotherapy and Radiation
NCT00392704 · SCRI Development Innovations, LLC, Other · Completed
Key facts
| NCT number | NCT00392704 |
|---|---|
| Title | Treatment of Head & Neck Cancer With Chemotherapy and Radiation |
| Official title | A Phase II Trial of Neoadjuvant Chemotherapy Plus Bevacizumab Followed By Concurrent Chemotherapy/Bevacizumab/Erlotinib/Radiation Therapy in the Treatment of Locally Advanced Squamous Carcinoma of the Head and Neck |
| Lead sponsor | SCRI Development Innovations, LLC, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug, Radiation |
| Interventions | Bevacizumab, Erlotinib, Paclitaxel, 5-FU, Radiation Therapy |
| Enrollment | 60 |
| Start date | Dec 1, 2006 |
| Primary completion | Aug 1, 2008 |
| Completion | May 1, 2012 |
| First posted | Oct 26, 2006 |
| Last update posted | Feb 22, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: